Nab-paclitaxel (Nab-P) in patients (pts) with HER2-ve advanced breast cancer (ABC): A focus on the elderly— Preliminary results of the GIM-13 AMBRA study. Validation of time to treatment change (TTC) ...
Phase 3 ASSURE Interim Data: Majority of People in the Study with ALP 1–1.67×ULN Achieved High and Sustained Composite ALP Normalization at 24 Months with Gilead’s Livdelzi (Seladelpar) – ALP Is a Key ...
IT has now been well established that the leukocyte alkaline phosphatase in chronic granulocytic leukemia is very low, whereas in morphologically similar cell populations of polycythemia rubra vera ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results